Skip to main content
Log in

An institutional experience with arterial atheroembolism

  • Original Articles
  • Published:
Annals of Vascular Surgery

Abstract

Seemingly minor blue-toe lesions resulting from atheroemboli are associated with unstable atherosclerotic plaques, which are at risk for causing recurrent emboli, tissue loss, and potentially death. At Washington University Medical Center, 62 patients (31 males and 31 females), ranging in age from 38 to 89 years (mean 62.8 ± 11.7 years), were treated for cutaneous manifestations of atheroembolic disease. Most patients (62%) had spontaneous bouts of atheroembolism, but 13 (21%) had recently undergone an inciting invasive radiologic study, 10 (16%) were on anticoagulation therapy, and one (2%) experienced abdominal trauma. In addition to the cutaneous manifestations, 18 patients (29%) also developed coincidental deterioration in renal function and four (6%) had intestinal infarction from atheroemboli. Arteriography in nearly all patients (97%) implicated the aorta and iliac arteries most commonly (80%), with the femoral (13%), popliteal (3%), and subclavian (3%) arteries less frequently incriminated. Forty-two patients underwent bypass grafting procedures (36 anatomic and six extra-anatomic) after exclusion of the native diseased artery, 20 patients had endarterectomies (six with additional bypass grafts), and five patients had no corrective vascular procedures. The 30-day operative mortality rate was 5% in this series. Nineteen patients (31%) required minor amputations, whereas two required major leg amputations. Thus limb salvage was possible in 86 of 88 (98%) limbs. No further episodes of atheroembolism occurred in the involved limbs during follow-up (1 to 53 months, mean 20.2 months). We advocate urgent arteriography and surgical correction or bypass with exclusion of the offending lesion. This aggressive approach results in maximal limb salvage, low operative mortality, and excellent long-term relief of embolization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Panum PL. Experimentelle Beitrage zur Lehre von der Emboli. Virchows Arch Pathol Anat 1862;25:308–310.

    Google Scholar 

  2. Flory CM. Arterial occlusions produced by emboli from eroded aortic atheromatous plaques. Am J Pathol 1945;21:549–565.

    Google Scholar 

  3. Otken LB. Experimental production of atheromatous embolization. AMA Arch Pathol 1959;68:685–689.

    Google Scholar 

  4. Snyder HE, Shapiro JL. A correlative study of atheromatous embolism in human beings and experimental animals. Surgery 1961;49:195–204.

    Google Scholar 

  5. Gore I, McCombs HL, Lindquist RL. Observations on the fate of cholesterol emboli. J Atheroscler Res 1964;4:527–535.

    Google Scholar 

  6. Warren BA, Vales O. The ultrastructure of the reaction of arterial walls to cholesterol crystals in atheroembolism. Br J Exp Pathol 1976;57:67–77.

    PubMed  Google Scholar 

  7. Karmody AM, Powers SR, Monaco VJ, et al. “Blue toe” syndrome. Arch Surg 1976;111:1263–1268.

    PubMed  Google Scholar 

  8. McGowan JA, Greenburg A. Cholesterol atheroembolic renal disease. Am J Nephrol 1986;6:135–139.

    PubMed  Google Scholar 

  9. Mashiah A, Pasik S, Hurwitz N. Massive atheromatous emboli to both kidneys: A fatal complication following aortic surgery. J Cardiovasc Surg 1988;29:60–62.

    Google Scholar 

  10. Kasinath BS, Lewis EJ. Eosinophilia as a clue to the diagnosis of atheroembolic renal disease. Arch Intern Med 1987; 147:1384–1385.

    PubMed  Google Scholar 

  11. Zatuchni J, Patel HK, Chiemchanya S. The “blue toe” syndrome with renal atheroembolism and failure. Angiology 1985;36:209–214.

    PubMed  Google Scholar 

  12. Kassirer JP. Atheroembolic renal disease. N Engl J Med 1969;280:812–818.

    PubMed  Google Scholar 

  13. Heggtveit HA. Coronary atheroembolism. N Engl J Med 1984;310:722.

    Google Scholar 

  14. Fitzgibbon GM, Keon WJ. Atheroembolic perioperative infarction during repeat coronary bypass surgery: Angiographic documentation in a survivor. Ann Thorac Surg 1987;43:218–219.

    PubMed  Google Scholar 

  15. Keon WJ, Heggtveit HA, Leduc J. Perioperative myocardial infarction caused by atheroembolism. J Thorac Cardiovasc Surg 1982;84:849–855.

    PubMed  Google Scholar 

  16. Forouhar FA, Mohit M, Gardner P, et al. Cholesterol embolism causing bleeding gastric ulcers. Ann Clin Lab Sci 1988; 18:260–265.

    PubMed  Google Scholar 

  17. Anderson WR, Richards AM, Weiss L. Hemorrhage and necrosis of the stomach and bowel due to atheroembolism. Am J Clin Pathol 1967; 48:30–38.

    PubMed  Google Scholar 

  18. Coppeto JR, Lessell S, Lessell IM, et al. Diffuse disseminated atheroembolism. Arch Ophthalmol 1984; 102:225–228.

    PubMed  Google Scholar 

  19. Weigent CE. Pulmonary atheroembolism complicating repair of an atherosclerotic abdominal aneurysm. Minn Med 1978; 61:15–16.

    PubMed  Google Scholar 

  20. Gibbons GW, Madras PN, Wheelock FC, et al. Aortoiliac reconstruction following renal transplantation. Surgery 1982; 91:435–437.

    PubMed  Google Scholar 

  21. Aujila ND, Greenberg A, Banner BF, et al. Atheroembolic involvement of renal allografts. Am J Kidney Dis 1989;13:329–332.

    PubMed  Google Scholar 

  22. Thurlbeck WM, Castleman B. Atheromatous emboli to the kidneys after aortic surgery. N Engl J Med 1957;257:442–447.

    PubMed  Google Scholar 

  23. Richards AM, Eliot RS, Kanjuh VI, et al. Cholesterol embolism. Am J Cardiol 1965;15:696–707.

    PubMed  Google Scholar 

  24. Young DK, Burton MF, Herman JH. Multiple cholesterol emboli syndrome simulating systemic necrotizing vasculitis. J Rheumatol 1986;13:423–426.

    PubMed  Google Scholar 

  25. Zaytsev P, Miller K, Pellettiere EV. Cutaneous cholesterol emboli with infarction clinically mimicking heparin necrosis —a case report. Angiology 1986;37:471–476.

    PubMed  Google Scholar 

  26. Moldveen-Geronimus M, Merriam JC. Cholesterol embolization: From pathological curiosity to clinical entity. Circulation 1967; 35:946–953.

    PubMed  Google Scholar 

  27. Bruns FJ, Segel DP, Adler S. Control of cholesterol embolization by discontinuation of anticoagulant therapy. Am J Med Sci 1978;275:105–108.

    PubMed  Google Scholar 

  28. Hyman BT, Landas SK, Ashman RF, et al. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 1987;82:1233–1237.

    PubMed  Google Scholar 

  29. Scully RE, Mark EJ, McNeely B. Case records of the Massachusetts General Hospital (case 30-1986). N Engl J Med 1986;315:308–315.

    PubMed  Google Scholar 

  30. Kazmier FJ. Shaggy aorta syndrome and disseminated atheromatous embolization. In Bergan JJ, Yao JST, eds. Aortic Surgery. Philadelphia: WB Saunders, 1989, pp 189–194.

    Google Scholar 

  31. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: A review of 221 cases in the English literature. Angiology 1987;38:769–784.

    PubMed  Google Scholar 

  32. Kealy WF. Atheroembolism. J Clin Pathol 1978; 31:984–989.

    PubMed  Google Scholar 

  33. Jones DB, Iannaccone PM. Atheromatous emboli in renal biopsies. Am J Pathol 1975;78:261–271.

    PubMed  Google Scholar 

  34. Handler FP. Clinical and pathologic significance of atheromatous embolization, with emphasis on an etiology of renal hypertension. Am J Med 1956;20:366–373.

    PubMed  Google Scholar 

  35. Dalakos TG, Streeten DHP, Jones D, et al. “Malignant” hypertension resulting from atheromatous embolization predominantly of one kidney. Am J Med 1974;57:135–138.

    PubMed  Google Scholar 

  36. Pollitt J, Lee BM. Renal failure from atheroembolism after translumbar aortography. J Am Geriatr Soc 1971;19:989–995.

    PubMed  Google Scholar 

  37. Ramirez G, O'Neill WM, Lambert R, et al. Cholesterol embolization: A complication of angiography. Arch Intern Med 1978;138:1430–1432.

    PubMed  Google Scholar 

  38. Kumpe DA, Zwerdlinger S, Griffin DJ. Blue digit syndrome: Treatment with percutaneous transluminal angioplasty. Radiology 1988;166:37–44.

    PubMed  Google Scholar 

  39. Brewer ML, Kinnison ML, Perler BA, et al. Blue toe syndrome: Treatment with anticoagulants and delayed percutaneous transluminal angioplasty. Radiology 1988;166:31–35.

    PubMed  Google Scholar 

  40. Kempczinski RF. Lower-extremity arterial emboli from ulcerating atherosclerotic plaques. JAMA 1979;241:807–810.

    PubMed  Google Scholar 

  41. Kaufman JL, Stark K, Brolin RE. Disseminated atheroembolism from extensive degenerative atherosclerosis of the aorta. Surgery 1987; 102:63–69.

    PubMed  Google Scholar 

  42. Mehigan JT, Stoney RJ. Lower extremity atheromatous embolization. Am J Surg 1976; 132:163–167.

    PubMed  Google Scholar 

  43. Fisher DF, Clagett GP, Brigham RA, et al. Dilemmas in dealing with the blue toe syndrome: Aortic versus peripheral source. Am J Surg 1984; 148:836–839.

    PubMed  Google Scholar 

  44. Dahlberg PJ, Frecentese DF, et al. Cholesterol embolism: Experience with 22 histologically proven cases. Surgery 1989; 105:737–746.

    PubMed  Google Scholar 

  45. Kwann JHM, Connolly JE. Peripheral embolism, an enigma. Arch Surg 1977;112:987–990.

    PubMed  Google Scholar 

  46. Colt HG, Begg RJ, Saporito JJ, et al. Cholesterol emboli after cardiac catheterization: Eight cases and a review of the literature. Medicine 1988;67:389–400.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Baumann, D.S., McGraw, D., Rubin, B.G. et al. An institutional experience with arterial atheroembolism. Annals of Vascular Surgery 8, 258–265 (1994). https://doi.org/10.1007/BF02018173

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02018173

Keywords

Navigation